556
Views
20
CrossRef citations to date
0
Altmetric
Editorial

Meningococcal serogroup B vaccines: will they live up to expectations?

, &
Pages 559-561 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maria Elena Santolaya, Miguel O'Ryan, María Teresa Valenzuela, Valeria Prado, Rodrigo F Vergara, Alma Muñoz, Daniela Toneatto, Gabriela Graña, Huajun Wang & Peter M Dull. (2013) Persistence of antibodies in adolescents 18−24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine. Human Vaccines & Immunotherapeutics 9:11, pages 2304-2310.
Read now
Muhamed-Kheir Taha & Ala-Eddine Deghmane. (2012) New recombinant vaccines for the prevention of meningococcal B disease. Vaccine: Development and Therapy 2, pages 15-22.
Read now
Marco AP Sáfadi & E David G McIntosh. (2011) Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies. Expert Review of Vaccines 10:12, pages 1717-1730.
Read now

Articles from other publishers (17)

Mahmoud M. Shehata, Ahmed Mostafa, Lisa Teubner, Sara H. Mahmoud, Ahmed Kandeil, Rabeh Elshesheny, Thamer A. Boubak, Renate Frantz, Luigi La Pietra, Stephan Pleschka, Ahmed Osman, Ghazi Kayali, Trinad Chakraborty, Mohamed A. Ali & Mobarak Abu Mraheil. (2019) Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV. Vaccines 7:2, pages 46.
Crossref
Duccio Medini, Maria Stella & James Wassil. (2015) MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine. Vaccine 33:23, pages 2629-2636.
Crossref
K.F.M. Zwiauer, M. Bröker & A. Banzhoff. (2014) Der neue Mehrfachkomponentenimpfstoff 4CMenB zum Schutz vor Erkrankungen durch Meningokokken der Serogruppe BA new multicomponent vaccine (4CMenB) to protect against serogroup B invasive meningococcal disease. Pädiatrie & Pädologie 49:S3, pages 3-12.
Crossref
Miguel O’Ryan, Jeffrey Stoddard, Daniela Toneatto, James Wassil & Peter M. Dull. (2013) A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program. Drugs 74:1, pages 15-30.
Crossref
Byeong-Jae Lee, Sang-Ho Lee, Min-Suk Song, Philippe Noriel Q. Pascua, Hyeok-il Kwon, Su-Jin Park, Eun-Ha Kim, Arun Decano, Se Mi Kim, Gyo Jin Lim, Doo-Jin Kim, Kyu-Tae Chang, Sang-Hyun Kim & Young Ki Choi. (2013) Adjuvant efficacy of mOMV against avian influenza virus infection in mice. Journal of Microbiology 51:5, pages 682-688.
Crossref
Bas van de Waterbeemd, Gijsbert Zomer, Patricia Kaaijk, Nicole Ruiterkamp, René H. Wijffels, Germie P. J. M. van den Dobbelsteen & Leo A. van der Pol. (2013) Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis. PLoS ONE 8:5, pages e65157.
Crossref
Bas van de Waterbeemd, Geert P. M. Mommen, Jeroen L. A. Pennings, Michel H. Eppink, René H. Wijffels, Leo A. van der Pol & Ad P. J. M. de Jong. (2013) Quantitative Proteomics Reveals Distinct Differences in the Protein Content of Outer Membrane Vesicle Vaccines. Journal of Proteome Research 12:4, pages 1898-1908.
Crossref
Muhammad Saleem, Stephen M. Prince, Stephen E. J. Rigby, Muhammad Imran, Hema Patel, Hannah Chan, Holly Sanders, Martin C. J. Maiden, Ian M. Feavers & Jeremy P. Derrick. (2013) Use of a Molecular Decoy to Segregate Transport from Antigenicity in the FrpB Iron Transporter from Neisseria meningitidis. PLoS ONE 8:2, pages e56746.
Crossref
Bas van de Waterbeemd, Gijsbert Zomer, Jan van den IJssel, Lonneke van Keulen, Michel H. Eppink, Peter van der Ley & Leo A. van der Pol. (2013) Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development. PLoS ONE 8:1, pages e54314.
Crossref
James Wassil, E David G McIntosh, Davide Serruto, Lisa DeTora, Michael Bröker & Alan Kimura. (2012) The early clinical development of a multicomponent vaccine against meningococcal serogroup B. Clinical Investigation 2:5, pages 503-517.
Crossref
Diana Lennon, Stewart Reid, Joanna Stewart, Catherine Jackson, Sue Crengle & Teuila Percival. (2012) Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic. Journal of Paediatrics and Child Health 48:3, pages 193-201.
Crossref
Muhammad Saleem, Stephen M. Prince, Hema Patel, Hannah Chan, Ian M. Feavers & Jeremy P. Derrick. (2012) Refolding, purification and crystallization of the FrpB outer membrane iron transporter from Neisseria meningitidis . Acta Crystallographica Section F Structural Biology and Crystallization Communications 68:2, pages 231-235.
Crossref
Mariagrazia Pizza, Lisa DeTora & James Wassil. (2012) Advances in meningococcal vaccines. Clinical Practice 9:1, pages 101-117.
Crossref
D. Moreno-Pérez, F.J. Álvarez García, J. Aristegui Fernández, F. Barrio Corrales, M.J. Cilleruelo Ortega, J.M. Corretger Rauet, J. González-Hachero, T. Hernández-Sampelayo Matos, M. Merino Moína, L. Ortigosa del Castillo & J. Ruiz-Contreras. (2012) Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations. Anales de Pediatría 76:1, pages 43.e1-43.e23.
Crossref
D. Moreno-Pérez, F.J. Álvarez García, J. Arístegui Fernández, F. Barrio Corrales, M.J. Cilleruelo Ortega, J.M. Corretger Rauet, J. González-Hachero, T. Hernández-Sampelayo Matos, M. Merino Moína, L. Ortigosa del Castillo & J. Ruiz-Contreras. (2012) Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2012. Anales de Pediatría 76:1, pages 42.e1-42.e23.
Crossref
D. Moreno-Pérez, F.J. Álvarez García, J. Arístegui Fernández, F. Barrio Corrales, M.J. Cilleruelo Ortega, J.M. Corretger Rauet, J. González-Hachero, T. Hernández-Sampelayo Matos, M. Merino Moína, L. Ortigosa del Castillo & J. Ruiz-Contreras. (2012) Calendario de vacunaciones de la Asociación Española de Pediatría: Recomendaciones 2012. Vacunas 13:1, pages 21-31.
Crossref
John B. RobbinsRachel SchneersonGuilin XieLars Å. Hanson & Mark A. Miller. (2011) Capsular polysaccharide vaccine for Group B Neisseria meningitidis , Escherichia coli K1, and Pasteurella haemolytica A2 . Proceedings of the National Academy of Sciences 108:44, pages 17871-17875.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.